Shilpa Medicare receives EU-GMP certification for two API manufacturing plants

23 Apr 2018 Evaluate

Shilpa Medicare has received EU-GMP certification from Austrian Agency, AGES for its two API Manufacturing Plants located at Raichur, Karnataka and Formulation Facility located at Jadcherla, Telangana. Austrian Agency, AGES carried out audit of said API plants between January 16 and January 24, 2018 and Formulation Facility between January 25 and January 31, 2018.

Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.

Shilpa Medicare Share Price

272.70 -5.85 (-2.10%)
21-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.55
Dr. Reddys Lab 1155.50
Cipla 1369.55
Zydus Lifesciences 876.10
Lupin 2139.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×